Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Egan

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
Psychiatry Research|January 31, 1995
Diurnal variation in tardive dyskinesiaT M Hyde, M F Egan, R J Brown, et al.
Journal of Psychiatric Research|March 1, 1997
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenicsS E Bachus, T M Hyde, M M Herman, et al.
The American Journal of Psychiatry|July 27, 2000
Relative risk of attention deficits in siblings of patients with schizophreniaM F Egan, T E Goldberg, T Gscheidle, et al.
Psychopharmacology|October 1, 1996
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidolM F Egan, Y Hurd, J Ferguson, et al.
Synapse (New York, N.Y.)|November 1, 1994
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesiasM F Egan, Y Hurd, T M Hyde, et al.
Brain Research|May 23, 1994
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movementsM B Knable, T M Hyde, M F Egan, et al.
Psychopharmacology|August 3, 2000
Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidolC M Bower, T M Hyde, M Zaka, et al.
The American Journal of Psychiatry|September 29, 2000
Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophreniaJ H Callicott, A Bertolino, M F Egan, et al.
Schizophrenia Research|May 5, 2009
The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblingsD I Shapiro, S Marenco, E H Spoor, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 1998
Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT studyM B Knable, M F Egan, A Heinz, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
Psychiatry Research|January 31, 1995
Diurnal variation in tardive dyskinesiaT M Hyde, M F Egan, R J Brown, et al.
Journal of Psychiatric Research|March 1, 1997
Abnormal cholecystokinin mRNA levels in entorhinal cortex of schizophrenicsS E Bachus, T M Hyde, M M Herman, et al.
The American Journal of Psychiatry|July 27, 2000
Relative risk of attention deficits in siblings of patients with schizophreniaM F Egan, T E Goldberg, T Gscheidle, et al.
Psychopharmacology|October 1, 1996
Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidolM F Egan, Y Hurd, J Ferguson, et al.
Synapse (New York, N.Y.)|November 1, 1994
Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesiasM F Egan, Y Hurd, T M Hyde, et al.
Brain Research|May 23, 1994
Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movementsM B Knable, T M Hyde, M F Egan, et al.
Psychopharmacology|August 3, 2000
Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidolC M Bower, T M Hyde, M Zaka, et al.
The American Journal of Psychiatry|September 29, 2000
Selective relationship between prefrontal N-acetylaspartate measures and negative symptoms in schizophreniaJ H Callicott, A Bertolino, M F Egan, et al.
Schizophrenia Research|May 5, 2009
The Premorbid Adjustment Scale as a measure of developmental compromise in patients with schizophrenia and their healthy siblingsD I Shapiro, S Marenco, E H Spoor, et al.
The British Journal of Psychiatry : the Journal of Mental Science|March 31, 1998
Altered dopaminergic function and negative symptoms in drug-free patients with schizophrenia. [123I]-iodobenzamide SPECT studyM B Knable, M F Egan, A Heinz, et al.
Pageof 7